More Cannabis Providers Leads To More Patient Acquisition
MIAMI, FL / ACCESSWIRE / September 4, 2018 / Novus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, and annuity, the nation's first carrier/aggregator offering a cannabis health plan, today announce its continues to sign up to their Provider Network additional legal medical cannabis dispensaries.
Cannabis dispensaries are experiencing the ever-increasing competitiveness as the cannabis retail market expands. As Novus continues to build bridges for those dispensaries that once turned down to participate in our Provider Network, these same entities are now seeing Novus' value by driving a customer base to their storefronts with higher than average monthly med purchases and gratuitous local advertising effort.
One particular marketing mechanism that in-network dispensary providers are partial to is the "Beaconing Technology". This authoritative form of advertising broadcasts Novus' marketing message to the cannabis consumer's mobile device when they are within 5 meters of the non-participating dispensary, the intent is to lure the consumer to Novus Cannabis MedPlan at a near by in-network dispensary.
Frank Labrozzi, Novus' Chairman and CEO, stated, "Our focus is a continual expansion of our sustainable insurance business model that offers THC and CBD Providers. As we continue to meet the cannabis consumer needs, at a profit, we focus to solve the high cost healthcare social issue to scale."
Novus is proud to introduce our Providers base:
We invite you to do your due diligence here:
Novus Capital Structure as of June 30, 2018:
About Novus
Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical cannabis industry, particularly in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as, health, life, accident and fixed annuities.
Novus medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state-licensed dispensary and the registered patient.
The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws, allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to Novus Medical Group. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.
Forward-Looking Statements
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact Information
Corporate:
Chairman and CEO
Frank Labrozzi
[email protected]
855-228-7355
Investors:
Hayden IR
[email protected]
917-658-7878
SOURCE: Novus Acquisition & Development
Corp.
https://www.accesswire.com/511234/Novus-Targets-9-Straight-Quarters-Of-Growth-and-Profitability-As-It-Expands-In-Network-Dispensaries